These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24261031)

  • 1. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
    Dooremont D; Decaestecker J; De Wulf D; Ghillebert G; Van Vlierberghe H; Van Dorpe J; Baert F
    Acta Gastroenterol Belg; 2013 Sep; 76(3):342-6. PubMed ID: 24261031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.
    Vernier-Massouille G; Cosnes J; Lemann M; Marteau P; Reinisch W; Laharie D; Cadiot G; Bouhnik Y; De Vos M; Boureille A; Duclos B; Seksik P; Mary JY; Colombel JF
    Gut; 2007 Oct; 56(10):1404-9. PubMed ID: 17504943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine induced nodular regenerative hyperplasia in IBD patients.
    Daniel F; Cadranel JF; Seksik P; Cazier A; Duong Van Huyen JP; Ziol M; Coutarel P; Loison P; Jian R; Marteau P
    Gastroenterol Clin Biol; 2005 May; 29(5):600-3. PubMed ID: 15980758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
    Bryant DL; Miles CJ; Gearry RB
    N Z Med J; 2010 Apr; 123(1313):74-6. PubMed ID: 20581898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Ehmsen L; Marko C; Breidert M
    Dtsch Med Wochenschr; 2008 May; 133(18):950-3. PubMed ID: 18431703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease.
    Suárez Ferrer C; Llop Herrera E; Calvo Moya M; Vera Mendoza MI; González Partida I; González Lama Y; Matallana Royo V; Calleja Panero JL; Abreu García L
    Rev Esp Enferm Dig; 2016 Feb; 108(2):79-83. PubMed ID: 26838489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine.
    Seksik P; Mary JY; Beaugerie L; Lémann M; Colombel JF; Vernier-Massouille G; Cosnes J
    Inflamm Bowel Dis; 2011 Feb; 17(2):565-72. PubMed ID: 20848502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
    Calabrese E; Hanauer SB
    J Crohns Colitis; 2011 Feb; 5(1):48-53. PubMed ID: 21272804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
    Musumba CO
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1025-37. PubMed ID: 24099468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
    Cohen-Ezra O; Avni Y; Morgenstern S; Ben-Ari Z
    Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W; Marlicz W; Smereczyński A; Lawniczak M; Lewosiuk A; Starzyńska T
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):398-402. PubMed ID: 20726808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal hypertension secondary to azathioprine in myasthenia gravis.
    Fonseca V; Havard CW
    Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.
    Gilissen LPL; Tajzai R; Romberg M; Pierik M; Stronkhorst A; Steenhuisen K; Van Bodegraven A; Daniels A; Wong D
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e102-e107. PubMed ID: 33136726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia.
    De Boer NK; Tuynman H; Bloemena E; Westerga J; Van Der Peet DL; Mulder CJ; Cuesta MA; Meuwissen SG; Van Nieuwkerk CM; Van Bodegraven AA
    Scand J Gastroenterol; 2008; 43(5):604-8. PubMed ID: 18415755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.
    Arnott ID; Ghosh S
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):569-73. PubMed ID: 10833103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
    Su C; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.